These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. Ergul A Hypertension; 2000 Jul; 36(1):62-7. PubMed ID: 10904013 [TBL] [Abstract][Full Text] [Related]
43. The endothelin system and its antagonism in chronic kidney disease. Dhaun N; Goddard J; Webb DJ J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557 [TBL] [Abstract][Full Text] [Related]
44. Interaction of endothelin with renal nerves modulates kidney function in spontaneously hypertensive rats. Girchev RA; Bäcker A; Markova PP; Kramer HJ Kidney Blood Press Res; 2006; 29(2):126-34. PubMed ID: 16864980 [TBL] [Abstract][Full Text] [Related]
45. ET-1 actions in the kidney: evidence for sex differences. Kittikulsuth W; Sullivan JC; Pollock DM Br J Pharmacol; 2013 Jan; 168(2):318-26. PubMed ID: 22372527 [TBL] [Abstract][Full Text] [Related]
46. Novel receptor antagonists welcome a new era in endothelin biology. Douglas SA; Meek TD; Ohlstein EH Trends Pharmacol Sci; 1994 Sep; 15(9):313-6. PubMed ID: 7992380 [No Abstract] [Full Text] [Related]
47. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats. Lee TM; Chung TH; Lin SZ; Chang NC J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935 [TBL] [Abstract][Full Text] [Related]
48. Endothelin: a mediator of renal disease progression. Bruzzi I; Remuzzi G; Benigni A J Nephrol; 1997; 10(4):179-83. PubMed ID: 9377723 [TBL] [Abstract][Full Text] [Related]
49. Endothelin and endothelin antagonists in chronic kidney disease. Kohan DE; Barton M Kidney Int; 2014 Nov; 86(5):896-904. PubMed ID: 24805108 [TBL] [Abstract][Full Text] [Related]
53. Role of collecting duct endothelin in control of renal function and blood pressure. Kohan DE Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R659-68. PubMed ID: 23986358 [TBL] [Abstract][Full Text] [Related]
54. A review of endothelin and hypertension in African-American individuals. Grubbs AL; Ergul A Ethn Dis; 2001; 11(4):741-8. PubMed ID: 11763297 [TBL] [Abstract][Full Text] [Related]
55. The role of endothelin in hypertension. Rothermund L; Paul M Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):451-6. PubMed ID: 9690046 [TBL] [Abstract][Full Text] [Related]
56. Endothelin-1 and the kidney--beyond BP. Dhaun N; Webb DJ; Kluth DC Br J Pharmacol; 2012 Oct; 167(4):720-31. PubMed ID: 22670597 [TBL] [Abstract][Full Text] [Related]
58. Role of endothelin-1 in hypertension. Iglarz M; Schiffrin EL Curr Hypertens Rep; 2003 Apr; 5(2):144-8. PubMed ID: 12642014 [TBL] [Abstract][Full Text] [Related]
59. A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update. Blazek O; Bakris GL Eur J Pharmacol; 2024 Sep; 979():176752. PubMed ID: 39047966 [TBL] [Abstract][Full Text] [Related]